# US 2025/0049839 A1 · Compositions and methods for targeting cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0049839 A1
- Document ID: US20250049839A1
- Status: Published application
- Kind: A1
- Application number: 18/933,959
- Filed: 2024-10-31
- Published: 2025-02-13
- Earliest claimed: 2018-03-29
- Assignees: Children's Medical Center Corporation; Politecnico Di Milano; Dana-Farber Cancer Institute, Inc.
- Applicants: Children's Medical Center Corporation; Politecnico di Milano; Dana-Farber Cancer Institute, Inc.
- Inventors: Marco Peviani; Alessandra Biffi; Davide Moscatelli; Umberto Capasso Palmiero; Renato Auriemma; Mattia Sponchioni; Letterio Salvatore Politi
- Web page: https://patentgrep.com/patent/US20250049839A1

## CPC

- A61K 31/785: Polymers containing nitrogen
- G01N 33/587: {Nanoparticles}
- A61K 9/145: {with organic compounds}
- A61K 31/655: Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
- A61K 31/662: Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K 47/545: {Heterocyclic compounds (A61K47/558 takes precedence)}
- A61K 47/58: obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K 47/6933: {the polymer being obtained by reactions only involving carbon to carbon, e.g. poly(meth)acrylate, polystyrene, polyvinylpyrrolidone or polyvinylalcohol}
- A61K 47/6935: {the polymer being obtained otherwise than by reactions involving carbon to carbon unsaturated bonds, e.g. polyesters, polyamides or polyglycerol}
- A61K 49/085: {conjugated systems}
- A61K 49/128: {comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone}
- A61K 49/1824: {coated or functionalised nanoparticles (liposomes A61K49/1812; nanoemulsions A61K49/1806; micelles A61K49/1809)}
- A61K 49/1854: {the organic macromolecular compound being obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly(meth)acrylate, polyacrylamide, polyvinylpyrrolidone, polyvinylalcohol}
- A61K 51/065: {conjugates with carriers being macromolecules}
- A61K 51/1244: {microparticles or nanoparticles, e.g. polymeric nanoparticles}
- C08F 290/061: {Polyesters; Polycarbonates}
- C08F 290/062: {Polyethers}
- C08F 293/005: {using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent}
- A61B 5/0071: {by measuring fluorescence emission}
- A61B 5/0075: {by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy (A61B5/0071 takes precedence)}
- A61B 5/4041: {Evaluating nerves condition}
- A61B 5/4887: {Locating particular structures in or on the body}
- C08F 2438/03: Use of a di- or tri-thiocarbonylthio compound, e.g. di- or tri-thioester, di- or tri-thiocarbamate, or a xanthate as chain transfer agent, e.g . Reversible Addition Fragmentation chain Transfer [RAFT] or Macromolecular Design via Interchange of Xanthates [MADIX]
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

The present invention provides compositions and methods for targeting cells for therapeutic and/or diagnostic purposes, e.g., delivery of therapeutic and/or diagnostic agents to a cell. Nanoparticles and polymers functionalized with capture molecules, reporter molecules, and/or therapeutic agents are provided for the treatment or prevention of disease, including neurological diseases associated with neuroinflammation, and cancer.

## Claims

### Claim 1

(canceled)

### Claim 2

A method of making a functionalized polymer comprising contacting a first monomer: 2-Methacryloyloxyethyl phosphorylcholine (MPC), and a second monomer: methacrylate/amide PEG comprising a functionalized amine or azide, in the presence of a radical and a thiocarbonylthio compound.

### Claim 3 (depends on 2)

The method of claim 2, wherein the functionalized polymer comprises Formula I

### Claim at position 4

4-6. (canceled)

### Claim 7 (depends on 2)

The method of claim 2, wherein the functionalized polymer comprises Formula II:

### Claim at position 6

8-12. (canceled)

### Claim 13

A functionalized polymer comprising a TSPO ligand or precursor or analog thereof covalently linked to a branched PEG polymer.

### Claim at position 8

14-20. (canceled)
